8 үр дүн
BACKGROUND
There is an overwhelming obesity problem in the United States of America and around the globe. This problem is caused mainly by lack of energy expenditure from the human body. Energy expenditure in the form of exercise (mobility) and environmental adaptation has shifted dramatically in
This invention relates to methods and formulations for the treatment of obesity.
BACKGROUND OF THE INVENTION
When it is required to bring about weight reduction in over-weight patients, it is naturally necessary to reduce their food intake, since the object of the weight-reduction treatment is to
This invention relates to methods and formulations for the treatment of obesity.
BACKGROUND OF THE INVENTION
When it is required to bring about weight reduction in over-weight patients, it is naturally necessary to reduce their food intake, since the object of the weight-reduction treatment is to
FIELD OF THE INVENTION
The present invention relates to veterinary medicine, in particular to the treatment and/or prevention of metabolic disorders in feline animals.
BACKGROUND OF THE INVENTION
Feline animals, e.g. cats, are affected by various metabolic disorders. A number of metabolic disorders
FIELD OF THE INVENTION
The present invention relates to veterinary medicine, in particular to the treatment and/or prevention of metabolic disorders in canine animals.
BACKGROUND OF THE INVENTION
Canine animals, e.g. dogs, are affected by various metabolic disorders. A number of metabolic disorders
CROSS REFERENCE TO RELATED APPLICATIONS
The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/JP2006/320611, filed Oct. 17, 2006, published in Japanese, which claims benefit of Japanese Patent Application No. 2005-321108, filed Nov. 4, 2005.
This application is a National Stage Application of PCT/EP2009/059527, filed 23 Jul. 2009, which claims benefit of U.S. Ser. No. 61/084,098, filed 28 Jul. 2008 and which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of the above
FIELD OF THE INVENTION
The present invention relates to novel 2-halo substituted compounds capable of modulating the G-protein-coupled receptor GPR40, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatment of conditions such as